Arvinas and Pfizer announce initial Phase 1b Data from the TACTIVE-U sub-study of Vepdegestrant in combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium Read more
AstraZeneca India receives CDSCO approval for Durvalumab for specified additional indication Read more
Signet Therapeutics announces IND approval by the FDA for world’s first targeted therapy for DGC Read more
Glenmark and Ichnos launch Ichnos Glenmark Innovation to accelerate new drug discovery in cancer treatment Read more
J&J acquisition of Ambrx bolsters cancer ADC portfolio amidst big pharma’s growing investment trend: GlobalData Read more